Literature DB >> 10731721

Development of a new inhibitor of glucosylceramide synthase.

M Jimbo1, K Yamagishi, T Yamaki, K Nunomura, K Kabayama, Y Igarashi, J I Inokuchi.   

Abstract

Analogs of the potent inhibitor of glucosylceramide (GlcCer) synthase, D-threo-1-phenyl-2-palmitoylamino-3-pyrrolidino-1-propanol (P4), based on substitutions in the palmitoyl group were made by means of a stereo-selective synthetic method in order to elucidate the role of the hydrophobic portion in both the inhibitory action toward the enzyme and the biological effects. While P4 strongly inhibited GlcCer synthase with an IC(50) of 0.5 microM in vitro, it also inhibited cell growth by 50% at the concentration of 7 microM. The shorter N-acyl chain analogs including decanoyl, octanoyl, and hexanoyl groups showed similar IC(50) values for GlcCer synthase (around 2 microM) but the hexanoyl analog exhibited only a slight inhibitory effect on cell growth, showing the dissociation between GlcCer depletion and cell growth. Several compounds which exhibit similar hydrophobicity to the hexanoyl analog of P4 were subsequently designed. We found that D-threo-1-phenyl-2-benzyloxycarbonylamino-3-pyrrolidino-1-pr opanol (PBPP) was a most potent inhibitor, showing an IC50 of 0.3 microM. In cultured cells, PBPP was able to deplete glycosphingolipids without affecting cell growth or the ceramide level.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10731721     DOI: 10.1093/oxfordjournals.jbchem.a022631

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  5 in total

1.  Property-based design of a glucosylceramide synthase inhibitor that reduces glucosylceramide in the brain.

Authors:  Scott D Larsen; Michael W Wilson; Akira Abe; Liming Shu; Christopher H George; Paul Kirchhoff; H D Hollis Showalter; Jianming Xiang; Richard F Keep; James A Shayman
Journal:  J Lipid Res       Date:  2011-11-04       Impact factor: 5.922

2.  Glycosphingolipid deficiency affects functional microdomain formation in Lewis lung carcinoma cells.

Authors:  J I Inokuchi; S Uemura; K Kabayama; Y Igarashi
Journal:  Glycoconj J       Date:  2000 Mar-Apr       Impact factor: 2.916

3.  Identification of potent and selective glucosylceramide synthase inhibitors from a library of N-alkylated iminosugars.

Authors:  Amar Ghisaidoobe; Pieter Bikker; Arjan C J de Bruijn; Frithjof D Godschalk; Eva Rogaar; Marieke C Guijt; Peter Hagens; Jerre M Halma; Steven M Van't Hart; Stijn B Luitjens; Vincent H S van Rixel; Mark Wijzenbroek; Thor Zweegers; Wilma E Donker-Koopman; Anneke Strijland; Rolf Boot; Gijs van der Marel; Herman S Overkleeft; Johannes M F G Aerts; Richard J B H N van den Berg
Journal:  ACS Med Chem Lett       Date:  2010-12-02       Impact factor: 4.345

4.  Targeting ceramide synthase 6-dependent metastasis-prone phenotype in lung cancer cells.

Authors:  Motoshi Suzuki; Ke Cao; Seiichi Kato; Yuji Komizu; Naoki Mizutani; Kouji Tanaka; Chinatsu Arima; Mei Chee Tai; Kiyoshi Yanagisawa; Norie Togawa; Takahiro Shiraishi; Noriyasu Usami; Tetsuo Taniguchi; Takayuki Fukui; Kohei Yokoi; Keiko Wakahara; Yoshinori Hasegawa; Yukiko Mizutani; Yasuyuki Igarashi; Jin-ichi Inokuchi; Soichiro Iwaki; Satoshi Fujii; Akira Satou; Yoko Matsumoto; Ryuichi Ueoka; Keiko Tamiya-Koizumi; Takashi Murate; Mitsuhiro Nakamura; Mamoru Kyogashima; Takashi Takahashi
Journal:  J Clin Invest       Date:  2015-12-07       Impact factor: 14.808

5.  β-Glucosylceramide From Allergic Mothers Enhances Offspring Responsiveness to Allergen.

Authors:  Matthew T Walker; Ryan P Ferrie; Aki Hoji; Lindsay M Schroeder-Carter; Jacob D Cohen; Ronald L Schnaar; Joan M Cook-Mills
Journal:  Front Allergy       Date:  2021-02-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.